Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity

Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats

(2018) Ernesto Martínez-Martínez et al.   JOURNAL OF HYPERTENSION

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update

(2018) Navin Suthahar et al.   Theranostics

Acute Kidney Injury

(2016) Anna Zuk et al.   Annual Review of Medicine

Galectin-3 inhibition prevents adipose tissue remodelling in obesity

(2016) E Martínez-Martínez et al.   INTERNATIONAL JOURNAL OF OBESITY

The growth of acute kidney injury: a rising tide or just closer attention to detail?

(2015) Edward D. Siew et al.   KIDNEY INTERNATIONAL

Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation

(2015) Miguel Angel Burguillos et al.   Cell Reports

The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries

(2015) Laurent Calvier et al.   JACC-Heart Failure

Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells

(2015) Yosuke Harazono et al.   Oncotarget

Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes

(2014) Lakhmir S. Chawla et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathophysiology of Cisplatin-Induced Acute Kidney Injury

(2014) Abdullah Ozkok et al.   Biomed Research International

Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3

(2012) Xiaoge Gao et al.   GLYCOCONJUGATE JOURNAL

Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community

(2012) Jennifer E. Ho et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3

(2012) Zexu Dang et al.   TRANSPLANTATION

Notice

(2012)   Kidney International Supplements

Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival

(2011) W.H. Wilson Tang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3

(2011) Alison C. MacKinnon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Galectin-3 – A jack-of-all-trades in cancer

(2011) Anna U. Newlaczyl et al.   CANCER LETTERS

Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial

(2011) Natalia Lopez-Andrès et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pathophysiology of ischemic acute kidney injury

(2011) Asif A. Sharfuddin et al.   Nature Reviews Nephrology

Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury

(2011) Maria Kolatsi-Joannou et al.   PLoS One

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

(2010) Dirk J. A. Lok et al.   Clinical Research in Cardiology

Mechanisms of Tubulointerstitial Fibrosis

(2010) M. Zeisberg et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

PKC-  Promotes Renal Tubular Cell Apoptosis Associated with Proteinuria

(2010) X. Li et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment

(2010) Y Wang et al.   Cell Death & Disease

Galectin-3: a novel mediator of heart failure development and progression

(2009) Rudolf A. de Boer et al.   EUROPEAN JOURNAL OF HEART FAILURE

Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis

(2008) Neil C. Henderson et al.   AMERICAN JOURNAL OF PATHOLOGY